intuniv 1mg modified-release tablets
shire pharmaceuticals ltd - guanfacine hydrochloride - modified-release tablet - 1mg
intuniv 2mg modified-release tablets
shire pharmaceuticals ltd - guanfacine hydrochloride - modified-release tablet - 2mg
intuniv 3mg modified-release tablets
shire pharmaceuticals ltd - guanfacine hydrochloride - modified-release tablet - 3mg
intuniv 4mg modified-release tablets
shire pharmaceuticals ltd - guanfacine hydrochloride - modified-release tablet - 4mg
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacine hydrochloride - attention deficit disorder with hyperactivity - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv must be used as a part of a comprehensive adhd treatment programme, typically including psychological, educational and social measures.,
intuniv xr tablet (extended-release)
takeda canada inc - guanfacine (guanfacine hydrochloride) - tablet (extended-release) - 1mg - guanfacine (guanfacine hydrochloride) 1mg - central alpha-agonists
intuniv xr tablet (extended-release)
takeda canada inc - guanfacine (guanfacine hydrochloride) - tablet (extended-release) - 2mg - guanfacine (guanfacine hydrochloride) 2mg - central alpha-agonists
intuniv xr tablet (extended-release)
takeda canada inc - guanfacine (guanfacine hydrochloride) - tablet (extended-release) - 3mg - guanfacine (guanfacine hydrochloride) 3mg - central alpha-agonists
intuniv xr tablet (extended-release)
takeda canada inc - guanfacine (guanfacine hydrochloride) - tablet (extended-release) - 4mg - guanfacine (guanfacine hydrochloride) 4mg - central alpha-agonists
tenex 1mg tablets
imported (united states) - guanfacine hydrochloride - oral tablet - 1mg